1. Home
  2. BIO vs MKSI Comparison

BIO vs MKSI Comparison

Compare BIO & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • MKSI
  • Stock Information
  • Founded
  • BIO 1952
  • MKSI 1961
  • Country
  • BIO United States
  • MKSI United States
  • Employees
  • BIO N/A
  • MKSI N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • MKSI Industrial Machinery/Components
  • Sector
  • BIO Industrials
  • MKSI Industrials
  • Exchange
  • BIO Nasdaq
  • MKSI Nasdaq
  • Market Cap
  • BIO 8.7B
  • MKSI 9.6B
  • IPO Year
  • BIO N/A
  • MKSI 1999
  • Fundamental
  • Price
  • BIO $329.78
  • MKSI $104.43
  • Analyst Decision
  • BIO Buy
  • MKSI Strong Buy
  • Analyst Count
  • BIO 4
  • MKSI 8
  • Target Price
  • BIO $369.00
  • MKSI $146.63
  • AVG Volume (30 Days)
  • BIO 201.2K
  • MKSI 766.5K
  • Earning Date
  • BIO 10-24-2024
  • MKSI 10-30-2024
  • Dividend Yield
  • BIO N/A
  • MKSI 0.84%
  • EPS Growth
  • BIO N/A
  • MKSI N/A
  • EPS
  • BIO N/A
  • MKSI 0.12
  • Revenue
  • BIO $2,562,604,000.00
  • MKSI $3,580,000,000.00
  • Revenue This Year
  • BIO N/A
  • MKSI N/A
  • Revenue Next Year
  • BIO $4.45
  • MKSI $10.03
  • P/E Ratio
  • BIO N/A
  • MKSI $874.11
  • Revenue Growth
  • BIO N/A
  • MKSI N/A
  • 52 Week Low
  • BIO $261.59
  • MKSI $63.44
  • 52 Week High
  • BIO $384.37
  • MKSI $147.40
  • Technical
  • Relative Strength Index (RSI)
  • BIO 55.50
  • MKSI 37.12
  • Support Level
  • BIO $326.40
  • MKSI $105.29
  • Resistance Level
  • BIO $338.79
  • MKSI $110.61
  • Average True Range (ATR)
  • BIO 7.90
  • MKSI 4.54
  • MACD
  • BIO 0.34
  • MKSI -0.90
  • Stochastic Oscillator
  • BIO 69.62
  • MKSI 2.40

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About MKSI MKS Instruments Inc.

MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.

Share on Social Networks: